Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-Bromo-4'-hydroxyacetophenone is an organic compound that features a bromo and hydroxyl group attached to a benzene ring, with an acetophenone group attached to the same ring. It is a pale beige solid with unique chemical properties that make it useful in various applications.

2491-38-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 2491-38-5 Structure
  • Basic information

    1. Product Name: 2-Bromo-4'-hydroxyacetophenone
    2. Synonyms: PTP INHIBITOR I;PROTEIN TYROSINE PHOSPHATASE INHIBITOR I;ALPHA-BROMO-4-HYDROXYACETOPHENONE;4-HYDROXYPHENACYL BR;4-HYDROXYPHENACYL BROMIDE;2-BROMO-1-(4-HYDROXY-PHENYL)-ETHANONE;2'-BROMO-4'-HYDROXYACETOPHENONE;2-BROMO-4'-HYDROXYACETOPHENONE
    3. CAS NO:2491-38-5
    4. Molecular Formula: C8H7BrO2
    5. Molecular Weight: 215.04
    6. EINECS: 219-655-0
    7. Product Categories: Aromatic Acetophenones & Derivatives (substituted);Aromatics;Inhibitors
    8. Mol File: 2491-38-5.mol
    9. Article Data: 81
  • Chemical Properties

    1. Melting Point: 123-126°C
    2. Boiling Point: 338.7 °C at 760 mmHg
    3. Flash Point: 158.6 °C
    4. Appearance: clear colorless to light yellow liquid
    5. Density: 1.622 g/cm3
    6. Refractive Index: 1.591
    7. Storage Temp.: -70°C
    8. Solubility: Chloroform (Slightly), Methanol (Slightly)
    9. PKA: 7.69±0.15(Predicted)
    10. Sensitive: Lachrymatory
    11. Stability: Hygroscopic
    12. BRN: 1865388
    13. CAS DataBase Reference: 2-Bromo-4'-hydroxyacetophenone(CAS DataBase Reference)
    14. NIST Chemistry Reference: 2-Bromo-4'-hydroxyacetophenone(2491-38-5)
    15. EPA Substance Registry System: 2-Bromo-4'-hydroxyacetophenone(2491-38-5)
  • Safety Data

    1. Hazard Codes: C,Xn
    2. Statements: 22-36
    3. Safety Statements: 26
    4. RIDADR: 1760
    5. WGK Germany: 1
    6. RTECS: AM5982000
    7. HazardClass: 8
    8. PackingGroup: III
    9. Hazardous Substances Data: 2491-38-5(Hazardous Substances Data)

2491-38-5 Usage

Uses

Used in Pharmaceutical Industry:
2-Bromo-4'-hydroxyacetophenone is used as a covalent inhibitor for protein tyrosine phosphatases (PTPs) due to its ability to covalently block the catalytic domain of specific phosphatases, such as SHP-1(ΔSH2) and PTP1B. This makes it a valuable compound in research related to diabetes, cancer, allergy, and inflammation, as these phosphatases play a role in regulating insulin signaling and cell differentiation.
Used in Chemical Synthesis:
2-Bromo-4'-hydroxyacetophenone can be utilized as an intermediate in the synthesis of various organic compounds, taking advantage of its reactive functional groups for further chemical reactions and the creation of more complex molecules.
Used in Research and Development:
Due to its unique structure and properties, 2-Bromo-4'-hydroxyacetophenone may be employed in research and development for the discovery and development of new drugs, materials, or chemical processes that can benefit from its specific reactivity and interactions with other molecules.

Preparation

Also obtained by reaction of pyridinium hydrobromide perbromide with 4-hydroxyacetophenone in THF at r.t. for 3 h.

in vitro

in previous study, the corresponding values of ptp inhibitor i against ptp1b were determined to be ki of 42 μm, kinact of 0.57 min-1, and kinact/ki of 1.4*104 m-1 min-1, respectively. this study also showed that α-bromoacetophenone such as ptp inhibitor i could provide an effective, neutral py mimetic inhibitor of ptps. while perturbation of the electronic properties of the phenyl ring did not significantly improve its potency against ptps, attachment of a proper peptidyl moiety to the para position could improve both the potency and the selectivity substantially. in addition, since the covalent ptp inhibitor complex could be cleaved to regenerate the ptp activity photolytically, ptp inhibitor i might provide a novel class of photolytic switch for controlling cellular signaling processes [1].

references

[1] arabaci g, yi t, fu h, porter me, beebe kd, pei d. alpha-bromoacetophenone derivatives as neutral protein tyrosine phosphatase inhibitors: structure-activity relationship. bioorg med chem lett. 2002 nov 4;12(21):3047-50.

Check Digit Verification of cas no

The CAS Registry Mumber 2491-38-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,4,9 and 1 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 2491-38:
(6*2)+(5*4)+(4*9)+(3*1)+(2*3)+(1*8)=85
85 % 10 = 5
So 2491-38-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H7BrO2/c1-5(10)7-3-2-6(11)4-8(7)9/h2-4,11H,1H3

2491-38-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Bromo-4'-hydroxyacetophenone

1.2 Other means of identification

Product number -
Other names PTP INHIBITOR I

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2491-38-5 SDS

2491-38-5Synthetic route

4-Hydroxyacetophenone
99-93-4

4-Hydroxyacetophenone

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

Conditions
ConditionsYield
With copper(ll) bromide In ethanol; chloroform for 3.5h; Reflux;99.3%
With copper(ll) bromide In ethyl acetate at 20℃; for 2h;96%
With bromine; zinc In water at 20℃; for 0.25h;94%
4-acetyloxyacetophenone
13031-43-1

4-acetyloxyacetophenone

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

Conditions
ConditionsYield
With bis(dimethylacetamide)hydrogen tribromide In methanol at 20 - 45℃; for 0.25h;96%
Multi-step reaction with 2 steps
1: CS2; bromine
2: aq.-ethanolic HBr
View Scheme
Multi-step reaction with 2 steps
1: bromine / chloroform / 3 h
2: hydrogenchloride / water / 4 h / Reflux
View Scheme
4-Hydroxyacetophenone
99-93-4

4-Hydroxyacetophenone

A

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

B

3-bromo-4-hydroxyacetophenone
1836-06-2

3-bromo-4-hydroxyacetophenone

Conditions
ConditionsYield
With phenyltrimethylammonium tribromide In methanol; chloroform for 0.5h; Product distribution; other reagent, var. solvents;A 15%
B 76%
acetic acid 4-(2-bromoacetyl)phenyl ester
41104-10-3

acetic acid 4-(2-bromoacetyl)phenyl ester

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

Conditions
ConditionsYield
With hydrogenchloride In water for 4h; Reflux;70%
With hydrogen bromide
methoxybenzene
100-66-3

methoxybenzene

2-Bromoacetyl bromide
598-21-0

2-Bromoacetyl bromide

A

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

B

2-(2-bromoacetyl)hydroxybenzene
2491-36-3

2-(2-bromoacetyl)hydroxybenzene

Conditions
ConditionsYield
With aluminium trichloride; 1,2-Dichloropropane
With aluminium trichloride; 1,2-Dichloropropane
4-Hydroxyacetophenone
99-93-4

4-Hydroxyacetophenone

A

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

B

2,2-dibromo-4'-hydroxyacetophenone

2,2-dibromo-4'-hydroxyacetophenone

Conditions
ConditionsYield
With bromine In 1,4-dioxane for 0.666667h; Ambient temperature;A 10.3 g
B 0.96 g
With bromine In 1,4-dioxane for 0.5h; Ambient temperature;A 10.3 g
B 0.96 g
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

A

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

B

2-bromo-1-<2-hydroxy-phenyl>-ethanone-(1)

2-bromo-1-<2-hydroxy-phenyl>-ethanone-(1)

Conditions
ConditionsYield
With aluminium trichloride at 140℃;
phenol
108-95-2

phenol

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 150 - 155 °C
2: AlCl3 / 140 °C
View Scheme
C10H8Br2O3

C10H8Br2O3

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

Conditions
ConditionsYield
Stage #1: C10H8Br2O3 With sodium In methanol for 3h;
Stage #2: With water In methanol
copper(II)bromide
7789-45-9

copper(II)bromide

4-Hydroxyacetophenone
99-93-4

4-Hydroxyacetophenone

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

Conditions
ConditionsYield
In chloroform; ethyl acetate
In chloroform; ethyl acetate
water
7732-18-5

water

sodium hydrogensulfite

sodium hydrogensulfite

4-Hydroxyacetophenone
99-93-4

4-Hydroxyacetophenone

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

Conditions
ConditionsYield
With bromine In tetrahydrofuran
pyrographite
7440-44-0

pyrographite

copper(II)bromide
7789-45-9

copper(II)bromide

4-Hydroxyacetophenone
99-93-4

4-Hydroxyacetophenone

A

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

B

6-bromo-2-[4'-(2'-p-toluenesulfonyloxyethoxy)phenyl]imidazo[1,2-a]pyridine

6-bromo-2-[4'-(2'-p-toluenesulfonyloxyethoxy)phenyl]imidazo[1,2-a]pyridine

Conditions
ConditionsYield
In chloroform; ethyl acetate
copper(II)bromide
7789-45-9

copper(II)bromide

4-Hydroxyacetophenone
99-93-4

4-Hydroxyacetophenone

A

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

B

6-bromo-2-(4 - hydroxyphenyl)imidazo[1,2-a]pyridine
956499-75-5

6-bromo-2-(4 - hydroxyphenyl)imidazo[1,2-a]pyridine

Conditions
ConditionsYield
In chloroform; ethyl acetate
4-hydroxypropiophenone
70-70-2

4-hydroxypropiophenone

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

Conditions
ConditionsYield
With bromine In acetic acid Cooling;
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

2-bromo-1-(4-hydroxy-3-nitrophenyl)ethanone
5029-61-8

2-bromo-1-(4-hydroxy-3-nitrophenyl)ethanone

Conditions
ConditionsYield
With nitric acid In methanol at 0 - 20℃; for 3h; Large scale;100%
With trifluoromethylsulfonic anhydride; tetramethylammonium nitrate In dichloromethane for 27h;93%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

2-methylpropan-2-thiol
75-66-1

2-methylpropan-2-thiol

2-tert-butylsulfanyl-1-(4-hydroxy-phenyl)-ethanone

2-tert-butylsulfanyl-1-(4-hydroxy-phenyl)-ethanone

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran100%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

(R)-((R)-quinuclidin-3-yl) 2-phenyl-2-(phenylamino)-acetate
1233329-45-7

(R)-((R)-quinuclidin-3-yl) 2-phenyl-2-(phenylamino)-acetate

(R)-1-(2-(4-hydroxyphenyl)-2-oxoethyl)-3-((R)-2-phenyl-2-(phenylamino)acetoxy)-1-azoniabicyclo[2.2.2]octane bromide
1233330-73-8

(R)-1-(2-(4-hydroxyphenyl)-2-oxoethyl)-3-((R)-2-phenyl-2-(phenylamino)acetoxy)-1-azoniabicyclo[2.2.2]octane bromide

Conditions
ConditionsYield
With I2 In ethyl acetate100%
In ethyl acetate at 20℃; for 15h;100%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

4-(1H-imidazol-4-yl)phenol
68535-65-9

4-(1H-imidazol-4-yl)phenol

Conditions
ConditionsYield
at 150℃; for 24h;99%
at 170 - 180℃; Inert atmosphere;52%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

ammonium thiocyanate
1147550-11-5

ammonium thiocyanate

1-(4-hydroxyphenyl)-2-thiocyanato-1-ethanone
56430-88-7

1-(4-hydroxyphenyl)-2-thiocyanato-1-ethanone

Conditions
ConditionsYield
Stage #1: ammonium thiocyanate With montmorillonite K10 clay In acetone at 20℃; for 0.666667h;
Stage #2: 2-bromo-1-(4'-hydroxyphenyl)-1-ethanone at 20℃; for 0.00833333h; Neat (no solvent); Grinding;
98%
In dichloromethane at 20℃;
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

Boc-Trp-OH
13139-14-5

Boc-Trp-OH

N-tBOC-L-tryptophan 4-hydroxyphenacyl ester
1365571-06-7

N-tBOC-L-tryptophan 4-hydroxyphenacyl ester

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide98%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

1-(4-aminophenyl)ethylidenethiosemicarbazide
7410-53-9

1-(4-aminophenyl)ethylidenethiosemicarbazide

4-(2-(2-(1-(4-aminophenyl)ethylidene)hydrazinyl)thiazol-4-yl)phenol

4-(2-(2-(1-(4-aminophenyl)ethylidene)hydrazinyl)thiazol-4-yl)phenol

Conditions
ConditionsYield
In isopropyl alcohol Microwave irradiation; Green chemistry;97.53%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

N-(3-hydroxyphenyl)thiourea
3394-05-6

N-(3-hydroxyphenyl)thiourea

3-(4-(4-hydroxyphenyl)thiazol-2-ylamino)phenol
758688-95-8

3-(4-(4-hydroxyphenyl)thiazol-2-ylamino)phenol

Conditions
ConditionsYield
In ethanol at 71℃; for 0.0125h; Microwave irradiation;96%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

α,α-dimethyl-p-hydroxyphenacyl acetate
20816-46-0

α,α-dimethyl-p-hydroxyphenacyl acetate

Conditions
ConditionsYield
With silver(I) acetate In N,N-dimethyl-formamide at 50℃; for 3h; Inert atmosphere; Darkness;96%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

sodium benzenesulfonate
873-55-2

sodium benzenesulfonate

1-(4-hydroxyphenyl)-2-(phenylsulfonyl)ethanone
896109-70-9

1-(4-hydroxyphenyl)-2-(phenylsulfonyl)ethanone

Conditions
ConditionsYield
With PEG-400 at 20℃; for 0.166667h;95%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

3-nitrophenylthiourea
709-72-8

3-nitrophenylthiourea

4-(2-(3-nitrophenylamino)thiazol-4-yl)phenol
824945-93-9

4-(2-(3-nitrophenylamino)thiazol-4-yl)phenol

Conditions
ConditionsYield
In ethanol at 71℃; for 0.0125h; Microwave irradiation;95%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

p-nitrophenylthiourea
3696-22-8

p-nitrophenylthiourea

4-(2-(4-nitrophenylamino)thiazol-4-yl)phenol
708280-53-9

4-(2-(4-nitrophenylamino)thiazol-4-yl)phenol

Conditions
ConditionsYield
In ethanol at 71℃; for 0.0125h; Microwave irradiation;95%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

thiourea
17356-08-0

thiourea

4-(2-aminothiazol-4-yl)phenol
40353-60-4

4-(2-aminothiazol-4-yl)phenol

Conditions
ConditionsYield
In ethanol at 71℃; for 0.0125h; Microwave irradiation;95%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

1-(dibenzo[b,d]furan-2-yl(phenyl)methyl)-2-methyl-1H-imidazole
1449604-26-5

1-(dibenzo[b,d]furan-2-yl(phenyl)methyl)-2-methyl-1H-imidazole

1-(dibenzo[b,d]furan-2-yl(phenyl)methyl)-3-(2-(4-hydroxyphenyl)-2-oxoethyl)-2-methyl-1H-imidazol-3-ium bromide

1-(dibenzo[b,d]furan-2-yl(phenyl)methyl)-3-(2-(4-hydroxyphenyl)-2-oxoethyl)-2-methyl-1H-imidazol-3-ium bromide

Conditions
ConditionsYield
In acetone; toluene at 20℃; Reflux;95%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

1-(dibenzo[b,d]furan-2-yl(phenyl)methyl)-1H-benzo[d]imidazole
1449604-27-6

1-(dibenzo[b,d]furan-2-yl(phenyl)methyl)-1H-benzo[d]imidazole

1-(dibenzo[b,d]furan-2-yl(phenyl)methyl)-3-(2-(4-hydroxyphenyl)-2-oxoethyl)-1H-benzo[d]imidazol-3-ium bromide
1449604-73-2

1-(dibenzo[b,d]furan-2-yl(phenyl)methyl)-3-(2-(4-hydroxyphenyl)-2-oxoethyl)-1H-benzo[d]imidazol-3-ium bromide

Conditions
ConditionsYield
In acetone; toluene at 20℃; Reflux;95%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

1-(1-(dibenzo[b,d]furan-2-yl)ethyl)-1H-imidazole
1449604-22-1

1-(1-(dibenzo[b,d]furan-2-yl)ethyl)-1H-imidazole

1-(1-(dibenzo[b,d]furan-2-yl)ethyl)-3-(2-(4-hydroxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide
1449604-31-2

1-(1-(dibenzo[b,d]furan-2-yl)ethyl)-3-(2-(4-hydroxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide

Conditions
ConditionsYield
In acetone; toluene at 20℃; Reflux;95%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

1-(dibenzo[b,d]furan-2-yl(phenyl)methyl)-1H-imidazole
1449604-25-4

1-(dibenzo[b,d]furan-2-yl(phenyl)methyl)-1H-imidazole

1-(dibenzo[b,d]furan-2-yl(phenyl)methyl)-3-(2-(4-hydroxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide
1449604-56-1

1-(dibenzo[b,d]furan-2-yl(phenyl)methyl)-3-(2-(4-hydroxyphenyl)-2-oxoethyl)-1H-imidazol-3-ium bromide

Conditions
ConditionsYield
In acetone; toluene at 20℃; Reflux;95%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

1-(1-(dibenzo[b,d]furan-2-yl)ethyl)-2-methyl-1H-imidazole
1449604-23-2

1-(1-(dibenzo[b,d]furan-2-yl)ethyl)-2-methyl-1H-imidazole

1-(1-(dibenzo[b,d]furan-2-yl)ethyl)-3-(2-(4-hydroxyphenyl)-2-oxoethyl)-2-methyl-1H-imidazol-3-ium bromide
1449604-39-0

1-(1-(dibenzo[b,d]furan-2-yl)ethyl)-3-(2-(4-hydroxyphenyl)-2-oxoethyl)-2-methyl-1H-imidazol-3-ium bromide

Conditions
ConditionsYield
In acetone; toluene at 20℃; Reflux;95%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

benzoyl chloride
98-88-4

benzoyl chloride

4'-benzoyloxy-2-bromoacetophenone
5324-15-2

4'-benzoyloxy-2-bromoacetophenone

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 20℃; for 2h; Inert atmosphere; Schlenk technique;95%
d(4)-methanol
811-98-3

d(4)-methanol

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

C9H6(2)H3BrO2

C9H6(2)H3BrO2

Conditions
ConditionsYield
Stage #1: 2-bromo-1-(4'-hydroxyphenyl)-1-ethanone With triphenylphosphine In tetrahydrofuran for 0.166667h; Cooling with ice;
Stage #2: d(4)-methanol With di-isopropyl azodicarboxylate In tetrahydrofuran at 20℃; for 2h; Cooling with ice;
94.5%
2-hydroxyphenylthiourea
1520-26-9

2-hydroxyphenylthiourea

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

2-(4-(4-hydroxyphenyl)thiazol-2-ylamino)phenol
1173282-18-2

2-(4-(4-hydroxyphenyl)thiazol-2-ylamino)phenol

Conditions
ConditionsYield
In ethanol at 71℃; for 0.0125h; Microwave irradiation;94%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

(4-aminosulfonylphenyl)thiourea
1718-39-4

(4-aminosulfonylphenyl)thiourea

4-(4-(4-hydroxyphenyl)thiazol-2-ylamino)benzenesulfonamide
708995-83-9

4-(4-(4-hydroxyphenyl)thiazol-2-ylamino)benzenesulfonamide

Conditions
ConditionsYield
In ethanol at 71℃; for 0.0125h; Microwave irradiation;94%
In ethanol; N,N-dimethyl-formamide at 80℃; for 5h;84%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

1-(1-(dibenzo[b,d]furan-2-yl)ethyl)-1Hbenzo[d]imidazole
1449604-24-3

1-(1-(dibenzo[b,d]furan-2-yl)ethyl)-1Hbenzo[d]imidazole

1-(1-(dibenzo[b,d]furan-2-yl)ethyl)-3-(2-(4-hydroxyphenyl)-2-oxoethyl)-1H-benzo[d]imidazol-3-ium bromide
1449604-47-0

1-(1-(dibenzo[b,d]furan-2-yl)ethyl)-3-(2-(4-hydroxyphenyl)-2-oxoethyl)-1H-benzo[d]imidazol-3-ium bromide

Conditions
ConditionsYield
In acetone; toluene at 20℃; Reflux;94%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

1-((benzofuran-2-yl)methyl)-1H-benzo[d]imidazole
1422034-47-6

1-((benzofuran-2-yl)methyl)-1H-benzo[d]imidazole

1-((benzofuran-2-yl)methyl)-3-(2-(4-hydroxyphenyl)-2-oxoethyl)-1H-benzo[d]imidazol-3-ium bromide
1454785-25-1

1-((benzofuran-2-yl)methyl)-3-(2-(4-hydroxyphenyl)-2-oxoethyl)-1H-benzo[d]imidazol-3-ium bromide

Conditions
ConditionsYield
In toluene Reflux;94%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

N4-methylpyrimidine-2,4-diamine
1004-18-8

N4-methylpyrimidine-2,4-diamine

4-(7-(methylamino)imidazo[1,2-a]pyrimidin-2-yl)phenol

4-(7-(methylamino)imidazo[1,2-a]pyrimidin-2-yl)phenol

Conditions
ConditionsYield
In acetone at 65℃; Inert atmosphere;94%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

2-(3,4-dimethoxyphenyl)-ethylamine
120-20-7

2-(3,4-dimethoxyphenyl)-ethylamine

2-[2-(3,4-dimethoxy-phenyl)-ethylamino]-1-(4-hydroxy-phenyl)-ethanone hydrochloride

2-[2-(3,4-dimethoxy-phenyl)-ethylamino]-1-(4-hydroxy-phenyl)-ethanone hydrochloride

Conditions
ConditionsYield
Stage #1: 2-(3,4-dimethoxyphenyl)-ethylamine In acetonitrile for 0.166667h; Cooling with ice;
Stage #2: 2-bromo-1-(4'-hydroxyphenyl)-1-ethanone In acetonitrile
94%
2-bromo-1-(4'-hydroxyphenyl)-1-ethanone
2491-38-5

2-bromo-1-(4'-hydroxyphenyl)-1-ethanone

4-Nitrophenylene-1,2-diamine
99-56-9

4-Nitrophenylene-1,2-diamine

4-(6-nitroquinoxalin-2-yl)phenol
1415328-10-7

4-(6-nitroquinoxalin-2-yl)phenol

Conditions
ConditionsYield
In dimethyl sulfoxide at 20℃;93.6%
In dimethyl sulfoxide at 20℃; for 10h;58%
In dimethyl sulfoxide at 20℃; for 0.166667h;58%

2491-38-5Relevant articles and documents

Synthesis and cardiovascular activity of metoprolol analogues

Melgar-Fernandez, Roberto,Demare, Patricia,Hong, Enrique,Rosas, Miguel Angel,Escalante, Jaime,Munoz-Muniz, Omar,Juaristi, Eusebio,Regla, Ignacio

, p. 191 - 194 (2004)

The synthesis of four novel analogues of metoprolol, a well-known β1-blocker used to reduce arterial blood pressure, is described. The preparation of (2S,2′S)-7, (2R,2′S)-7, (2R,2′R)-8, and (2S,2′R)-8 was based on the reaction of racemic 2-[4-(2′- methoxyethyl)-phenoxymethyl]-oxirane (4) with (R)- or (S)-2-amino-1-butanol. Salient characteristics of analogues 7 and 8 relative to metoprolol are the incorporation of an additional stereogenic center, as well as a methyl group and a hydroxyl function on the nitrogen-containing chain. These novel derivatives present significant hypotensive and bradycardiac activity, although no blocking action toward β1 and β2 adrenergic receptor.

Easy synthesis of β-O-4 type lignin related polymers

Kishimoto, Takao,Uraki, Yasumitsu,Ubukata, Makoto

, p. 1067 - 1073 (2005)

The β-O-4 structure is the most abundant substructure in lignin. Lignin related polymers composed of only the β-O-4 structure were prepared using simple aromatic compounds as starting materials. Acetophenone derivatives were brominated, polymerized in the presence of K2CO3 and reduced with NaBH4 to give the lignin related polymers. These are linear polymers which resemble natural lignins in their structures, although they do not have a γ-hydroxymethyl group. The number average degree of polymerization (DPn) was determined with peracetate of the polymers by gel permeation chromatography. The DPn of guaiacyl type polymers ranged from 15.2-21.4, where the value for the syringyl type was 11.3 and for the p-hydroxyphenyl type 16.9. The Guaiacyl type polymer was very soluble in usual lignin solvents such as 1,4-dioxane-water (96:4, v/v) and DMSO, but only slightly soluble in acetone-water (9:1, v/v). The Royal Society of Chemistry 2005.

First synthesis of tabamides A–C and their derivatives: In vitro nitric oxide inhibitory activity

Damodar, Kongara,Jeon, Sung Ho,Lee, Jeong Tae,Shin, Sooyong

supporting information, (2021/11/10)

The first synthesis of natural phenolic amides, tabamides A–C (1–3), and their derivatives (4–12) was accomplished using Stobbe condensation and amide coupling reactions as key steps. The in vitro nitric oxide (NO) inhibitory effects of these compounds in LPS-induced RAW-264.7 macrophages were evaluated as an indicator of anti-inflammatory activity. All compounds tested had a concentration-dependent inhibitory effect on NO production by RAW-264.7 macrophages without significant cytotoxicity. Compound 6, a tabamide A derivative (IC50 = 82.6 μM), followed by tabamide A (1, IC50 = 100.7 μM), was the most potent from the series. The present study revealed that tabamide A (1) could be considered as a lead structure to develop NO production-targeted anti-inflammatory agents.

Novel Aryl-Substituted Pyrimidones as Inhibitors of 3-Mercaptopyruvate Sulfurtransferase with Antiproliferative Efficacy in Colon Cancer

Bantzi, Marina,Augsburger, Fiona,Loup, Jérémie,Berset, Yan,Vasilakaki, Sofia,Myrianthopoulos, Vassilios,Mikros, Emmanuel,Szabo, Csaba,Bochet, Christian G.

, p. 6221 - 6240 (2021/05/06)

The enzyme 3-mercaptopyruvate sulfurtransferase (3-MST) is one of the more recently identified mammalian sources of H2S. A recent study identified several novel 3-MST inhibitors with micromolar potency. Among those, (2-[(4-hydroxy-6-methylpyrimidin-2-yl)sulfanyl]-1-(naphthalen-1-yl)ethan-1-one) or HMPSNE was found to be the most potent and selective. We now took the central core of this compound and modified the pyrimidone and the arylketone sides independently. A 63-compound library was synthesized; compounds were tested for H2S generation from recombinant 3-MST in vitro. Active compounds were subsequently tested to elucidate their potency and selectivity. Computer modeling studies have delineated some of the key structural features necessary for binding to the 3-MST's active site. Six novel 3-MST inhibitors were tested in cell-based assays: they exerted inhibitory effects in murine MC38 and CT26 colon cancer cell proliferation; the antiproliferative effect of the compound with the highest potency and best cell-based activity (1b) was also confirmed on the growth of MC38 tumors in mice.

Nucleus-independent chemical shift (NICS) as a criterion for the design of new antifungal benzofuranones

González-Chávez, Marco Martín,González-Chávez, Rodolfo,Méndez, Francisco,Martínez, Roberto,Ni?o-Moreno, Perla Del Carmen,Ojeda-Fuentes, Luis Enrique,Richaud, Arlette,Zerme?o-Macías, María de los ángeles

, (2021/08/30)

The assertion made by Wu et al. that aromaticity may have considerable implications for molecular design motivated us to use nucleus-independent chemical shifts (NICS) as an aromaticity criterion to evaluate the antifungal activity of two series of indol-4-ones. A linear regression analysis of NICS and antifungal activity showed that both tested variables were significantly related (p –1 for Candida glabrata, Candida krusei and Candida guilliermondii with compounds 15-32, 15-15 and 15-1. The MIC for filamentous fungi was 1.95 μg·mL–1 for Aspergillus niger for compounds 15-1, 15-33 and 15-34. The results obtained support the use of NICS in the molecular design of compounds with antifungal activity.

Benzo[d]thiazole-2-thiol bearing 2-oxo-2-substituted-phenylethan-1-yl as potent selectivelasBquorum sensing inhibitors of Gram-negative bacteria

Quoc, Thang Nguyen,Thanh, Tung Truong,Xuan, Huy Luong

, p. 28797 - 28808 (2021/09/22)

Quorum sensing is a well-known term for describing bacterial cell-cell communication. Bacteria use quorum sensing pathways to respond to external factors such as nutrient availability, defense mechanisms, and coordinate host toxic behaviors such as biofilm formation, virulence production, and other pathogenesis. Discovery of novel compounds which inhibit quorum sensing without being antibiotic are currently emerging fields. Herein, the library of fifteen benzo[d]thiazole/quinoline-2-thiol bearing 2-oxo-2-substituted-phenylethan-1-yl compounds was designed, synthesized and evaluated to find novel quorum sensing inhibitors. Firstly, compounds were evaluated for their growth inhibitory activities at high concentrations up to 1000 μg mL?1towardPseudomonas aeruginosa. Under our conditions, twelve compounds showed moderate growth inhibitory activities in the concentration tested. To our delight, three compounds3,6and7do not affect the growth of the bacteria which were chosen for the evaluation of quorum sensing inhibitor activities. In theLasBsystem, our compounds3,6,7showed promising quorum-sensing inhibitors with IC50of 115.2 μg mL?1, 182.2 μg mL?1and 45.5 μg mL?1, respectively. In thePqsRsystem, no activity observed suggesting that the selectivity of the compound toward theLasBsystem. In addition,7showed the moderate anti-biofilm formation ofPseudomonas aeruginosa. Docking studies revealed that3,6and7binding to the active site ofPseudomonas aeruginosaquorum sensingLasRsystem with better affinity compared to reference compounds4-NPO. Finally, computation calculations suggest that compounds are a good template for further drug development.

Synthesis and preliminary photopolymerization evaluation of novel photoinitiators containing phototrigger to overcome oxygen inhibition in the UV- curing system

Chen, Wenbin,Wang, Lei,Liu, Xinyue,Chen, Bo,Zhao, Guofeng

, (2019/11/26)

In this work, two types of novel photoinitiaors containing phototrigger were prepared to overcome oxygen inhibition in the UV- curing system in the absence of hydrogen donor. The structures of prepared novel photoinitiators were determined by nuclear magnetic resonance (NMR) and high resolution MS (HR[sbnd]MS) spectra data. The photo chemical behavior and photo-reactivity were also evaluated by ultraviolet-visible (UV–vis) spectroscopy and real-time Fourier transform infrared spectroscopy (RT-FTIR), respectively. The results show the prepared photoinitiators exhibit remarkable redshift compared to the commercial BP (benzophenone) and Irgacure 907 (2-methyl-1-(4-methylsulfanylphenyl)-2-morpholin-4-ylpropan-1-one), fast photolysis by C[sbnd]S bond, good photo initiation and significant overcoming oxygen inhibition for some compounds, which can be used as one-component photoinitiator candidates.

Novel thiazole–pyrazolone hybrids as potent ACE inhibitors and their cardioprotective effect on isoproterenol-induced myocardial infarction

You, Hongwen,Su, Xinyou,Su, Guoying

, (2020/08/27)

A facile synthesis of a group of novel thiazole–pyrazolone hybrids and their investigation for angiotensin-converting enzyme (ACE) inhibition are reported in this study. These compounds were synthesized using a well-known approach, based on the condensation of ethyl acetoacetate with thiazolylhydrazines, and characterized by various spectroscopic and analytical techniques. The entire set of compounds displayed a moderate-to-excellent inhibitory activity against ACE. In particular, compound 4i was found to be the most potent ACE inhibitor and was further studied for cardioprotective effects against isoproterenol (ISO)-induced myocardial infarction (MI) in rats. Compound 4i improved the cardiac function and prevented cardiac injury induced by ISO in Sprague Dawley rats. The levels of oxidative stress and proinflammatory cytokines were also restored to near normal by 4i as compared with the ISO group. In the Western blot analysis, compound 4i prevented mitochondrial apoptosis after MI by downregulating the expression of cleaved caspase-3 and Bax, with the upregulation of Bcl-2, as compared with the ISO group.

Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: Structure-activity relationship, in vitro and in vivo study

Ma, Weifeng,Chen, Peng,Huo, Xiansen,Ma, Yufeng,Li, Yanhong,Diao, Pengcheng,Yang, Fang,Zheng, Shengquan,Hu, Mengjin,You, Wenwei,Zhao, Peiliang

, (2020/10/08)

Based on our prior work, we reported the design, synthesis, and biological evaluation of fifty-two new triazolothiadiazine-based analogues of CA-4 and their preliminary structure-activity relationship. Among synthesized compounds, Iab was found to be the most potent derivative possessing IC50 values ranging from single-to double-digit nanomolar in vitro, and also exhibited excellent selectivity over the normal human embryonic kidney HEK-293 cells (IC50 > 100 μM). Further mechanistic studies revealed that Iab significantly blocked tubulin polymerization and disrupted the intracellular microtubule network of A549 cells. Moreover, Iab induced G2/M cell cycle arrest by regulation of p-cdc2 and cyclin B1 expressions, and caused cell apoptosis through up-regulating cleaved PARP and cleaved caspase-3 expressions, and down-regulating of Bcl-2. Importantly, in vivo, Iab effectively suppressed tumor growth of A549 lung cancers in a xenograft mouse model without obvious signs of toxicity, confirming its potential as a promising candidate for cancer treatment.

ANTIBACTERIAL COMPOUNDS

-

Page/Page column 85-86, (2019/05/22)

The present invention relates to compounds of general formula (II),to compositions comprising these compounds and to methods of treating Enterobacteriaceae bacterial diseases and infections using the compounds. The compounds find application in the treatment of infection with, and diseases caused by, Enterobacteriaceae.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2491-38-5